The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center

Bone Marrow Transplant. 2016 Nov;51(11):1496-1498. doi: 10.1038/bmt.2016.149. Epub 2016 Jun 6.

Authors

S K Bae¹, T Gushima¹, N Saito², I Yamanaka², T Shimokawa², Y Matsuo², S Yoshida², I Kawano², H Henzan², S Shimoda³, T Eto², K Takahashi¹

Affiliations

¹ The Center for Liver Disease, Hamanomachi Hospital, Fukuoka, Japan.
² Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
³ Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan.

PMID: 27272453
DOI: 10.1038/bmt.2016.149

No abstract available

Publication types

Letter

MeSH terms

Adult
Antiviral Agents / therapeutic use
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Hepatitis B Antibodies / blood*
Hepatitis B virus / physiology*
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
Transplantation, Homologous
Virus Activation*

Substances

Antiviral Agents
Hepatitis B Antibodies